Bio-Rad Gets 10X Genomics' Antitrust Claims Trimmed

Law360 (August 31, 2020, 10:34 PM EDT) -- Bio-Rad Laboratories Inc. was dealt a partial victory in its patent dispute against life sciences company 10X Genomics Inc. when a Massachusetts federal judge on Monday whittled down some antitrust counterclaims Bio-Rad had called "implausible."

In a 51-page order, U.S. District Judge William G. Young partially granted Bio-Rad's request to dismiss 10X Genomics' counterclaims in the parties' dispute over whether 10X Genomics' biological analysis products stepped on Bio-Rad and Harvard University's intellectual property.

10X Genomics said Bio-Rad illegally acquired a competitor to gain monopoly power in three different markets. Bio-Rad had slammed the allegations as "implausible," accusing the company of spinning...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!